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providing reproducible results? Although, in this case,Beyond PCR: Biotechnology
the laurels went exclusively to KaryB. Mullis, who sharedas an Emerging Culture the 1993 Nobel Prize for chemistry, Cetus’ scientists
contribution, which ultimately ended up in a drawer of
Making PCR. A Story of Biotechnology. history, proved significant enough to justify an expola-
rion of this issue.By Paul Rabinow.
Chicago: The University of Chicago Press. (1996). 190 Hence, more than an account of the invention of PCR,
Rabinow’s working approach should be viewed as “anpp. $22.50
experiment in posing the problem of who hasthe author-
ity—and responsibility—to represent experience and
knowledge.” Cetus Corporation offered a privileged re-Far from limiting his work toa descriptionof a fundamen-
search environment where team spirit boosted motiva-tal discovery that ultimately transformed the practices
tion. The breakthrough of PCR and its consequent firstand potential of molecular biology, Paul Rabinow’s Mak-
Nobel Prize based on research performed in a start-ing PCR is a true voyage into the emerging environment
up biotechnology company, is significant: it should beof biotechnology during the eighties.
understood as the recognition that start-up biotechnol-The author, professor of anthropology at the Univer-
ogy companies are able to produce creative researchsity of California, Berkeley, defines himself as “curious
projects. Cetus’ working ambiance and managementabout the form of life in the making both within the labs
style made it possible for scientists to pursue experi-and beyond (as tentative, divergent, and emergent as it
ments aimed at proving that the concept of PCR works,is).” As such, Rabinow chose to explore the steps and
despite initial doubts about the outcome of such experi-circumstances of how (and by whom) the polymerase
ments. Concluding his work, with what should be seenchain reaction (PCR) was conceived at Cetus Corpora-
as an overall optimistic vision towards future research,tion, the first recombinant DNA start-up company,
Paul Rabinow qualifies Cetus scientists “as earnest, in-founded in 1971. In the perspective of this ethnographic
telligent, hardworking, and reasonably optimistic. Theseapproach, Cetus should be considered, as defined by
Americans are real professionals (...). Their scientificthe author, to be a “fortuitous space of experimenta-
practice, they firmly believe, contributes to a generaltion,” in which one may see “a certain kind of instrumen-
broadening of scientific understanding and technicaltalization of sites, subjects, and objects coming to-
mastery, to an eventual improvement of public health,gether, for a time, into a contingent ensemble.” For his
and even to the betterment of society.”part, Rabinow was concerned about learning enough
As much as PCR became a milestone in research,molecular biology to form his own understanding of the
Making PCR provides a fundamental contribution to thenew challenges raised by the advancements in science.
understanding of how such discoveries may happen andWhat make Rabinow’s work positively fascinating,
how an idea ends up reshaping research perspectives.and accessible to both scientists and neophytes, are
Far from simply describing the fierce competition be-the insights it provides into what could be characterized
tween laboratories, by referring to major philosophersas the new “culture” of biotechnology, a culture shaped
of sciences, Rabinow explores the meaning of being aby the encounter of two distinct worlds: university scien-
scientist today.tists and industry. An encounter of people having left
their respective and until then supposedly opposed
backgrounds, to join the high-risk industry, a milieu itself
Adam Telermanin constant evolution. Its actors were concerned with
Robert B. Amsoncombining academic standards of research and profit-
Cancer Genetics Programability. As a matter of fact, witnessing the emergence
Foundation Jean Daussetof the promising era of new techniques such as cloning,
Human Polymorphism Study Center CEPHgenetic engineering, and DNA recombination, scientists
27, rue Juliette Doduwere even more encouraged to apply research progress
75010 Paristo potential therapeutic utility rapidly, instead of losing
Franceprecious time in writing grants and assuming heavy
teaching loads.
As such, PCR, by extending the ability to identify and
manipulate genetic material, undoubtedly deserves to Books Received
be described to any reader. Nevertheless, Making PCR
sheds new light on questions that are of concern to
Behe, Michael J. (1996). Darwin’s Black Box. Free Press, New York.every scientist. The author raises a fundamental issue:
289 pp. $25.what are thecriteria underlying the definition of an inven-
tion? Is it merely a technique? Should one focus on its Bell, R.M., Exton, J.H., and Prescott, S.M. (1996). Handbook of
Lipid Research. Plenum Press, New York. 316 pp. $89.50.conceptualization, despite other scientists’ contribu-
tions in making this concept work? Or would it be more Biswas, B.B., and Biswas, S. (1996). Subcellular Biochemistry Vol
appropriate to use such a term only when the concept 26 myo-Inositol Phosphates, Phosphoinositides, and Signal Trans-
duction. Plenum Press, New York. 421 pp. $125.00.has been proven to work in an experimental system
Cell
708
Carey, P.R. (1996). Protein Engineering and Design. Academic
Press, San Diego, California. 361 pp. $79.95.
Cotter, T.J., and Martin, S.J. (1996). Techniques in Apoptosis: A
User’s Guide. Portland Press, Ltd., London. 333 pp. $120.00.
Diamandis, E.P., and Christopoulos, T.K. (1996). Immunoassay.
Academic Press, San Diego, California. 579 pp. $69.95.
Doolittle, R.F. (1996). Methods in Enzymology. Academic Press, San
Diego, California. 711 pp. $110.00.
Elles, R. (1996). Molecular Diagnosis of Genetic Diseases. Humana
Press, Totowa, New Jersey. 356 pp. $69.50.
Eun, H.-M. (1996). Enzymology Primer for Recombinant DNA Tech-
nology. Academic Press, San Diego, California. 702 pp. $125.00.
Fiskum, G. (1996). Neurodegenerative Diseases Molecular and Cel-
lular Mechanisms and Therapeutic Advances. Plenum Publishing,
New York. 482 pp. $135.00.
Griffin, D.H. (1996). Fungal Physiology. Wiley Publishers, New York.
458 pp. $42.95.
Grossblatt, N. (1996). Upstream:Salmon & Society in the Pacific
Northwest. National Academy Press, Washington, D.C. 452 pp.
$44.95.
Karger, B.L., and Hancock, W.S. (1996). Methods of Enzymology,
Volume 270, Part A. Academic Press, San Diego, California. 622 pp.
$90.00.
Karger, B.L., and Hancock, W.S. (1996). Methods in Enzymology,
Volume 271, Part B. Academic Press, San Diego, California. 555 pp.
$90.00.
Kibbler, C., Mackenzie, D., and Odds, F. (1996). Principles and
Practices of Clinical Mycology. Wiley Publishers, New York. 276 pp.
$80.00.
Lancaster, J. (1996). Nitric Oxide: Principles and Actions. Academic
Press, San Diego, California. 355 pp. $79.95.
Narahashi, T. (1996). Ion Channels. Plenum Press, New York. 457
pp. $110.00.
Packer, L. (1996). Methods in Enzymology, Volume 268. Academic
Press, San Diego, California. 555 pp. $95.00.
Paradise, L.J., Bendinelli, M., and Friedman, H. (1996). Enteric In-
fections and Immunity. Plenum Publishing, New York. 272 pp.
$79.50.
Raizada, M.K., Phillips, M.I., and Summers, C. (1996). Advances in
Experimental Medicine and Biology Vol. 396 : Recent Advances in
Cellular and Molecular Aspects of Angiotensin Receptors. Plenum
Press, New York. 270 pp. $85.00.
Rissler, J., and Mellon, M. (1996). The Ecological Risks of Engi-
neered Crops. The MIT Press, Cambridge, Massachusetts. 159 pp.
$16.95.
Rudolph, F.B., and McIntire, L.V. (1996). Biotechnology: Science,
Engineering, and Ethical Challenges for the 21st Century. Joseph
Henry Press, Washington, D.C. 278 pp. $34.95.
Setlow, J.K. (1996). Genetic Engineering Principles and Methods.
Plenum Press, New York. 289 pp. $79.50.
Smolensky, M.H., and Rensing, L. (1996). Chronobiology Interna-
tional The Journal of Biological and Medical Rhythm Research. Mar-
cel Dekker, Monticello, New York. 80 pp. $175.00.
Tomiuk, J., Wohrmann, K., and Sentker, A. (1996). Transgenic Or-
ganisms: Biological andSocial Implications. Birkhauser, Basel, Swit-
zerland. 263 pp. $83.95.
Weinberg, R.A. (1996). Racing to the Beginning of the Road - The
Search for the Origin of Cancer. Harmony Books, New York. 270
pp. $27.50.
Wirth, J. (1996). Color Atlas of Genetics. Thieme, New York. 411 pp.
$29.00.
